ChemoMetec and Roche Diagnostics partner to integrate cell counting and bioprocess monitoring systems
EU Joint Clinical Assessment enters second year as pharmaceutical companies adapt evidence strategies
Jazz Pharmaceuticals agrees $820 million Actio Biosciences acquisition to add precision epilepsy therapy ABS-1230
Commentaires